Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > heads out of our asses
View:
Post by bullpen14 on Jun 23, 2017 11:32am

heads out of our asses

We all may take a hit here, but come on... we knew this consolodation was inevitable and probably years over due. Obviously a tough call, but smart managment makes room for institutional investors. Prior managment dragged this comapnies progress and Silva likely has no choice but to bring it up to speed.
Comment by Actuarial on Jun 23, 2017 11:38am
Silva at least have a choice not to spend the $120,000 on PR for nothing ...... Silva at least have a choice to communicate with investors like Danter in the past ...... What she did? Consolidation when the SP at $0.25. Will see what the next soon.
Comment by Kipk20122 on Jun 23, 2017 12:13pm
Yes, But Timing is Everything. If There is No Significant PR coming, then this will bleed way lower after R/S. I also assume they will be doing some sort of financing, which makes SP depreciation even worse.
Comment by XRRH2008 on Jun 23, 2017 12:36pm
Sadly, I think thats their plan. Consolidate then do a financing. Shareholder value erosion followed by new dilution. 
Comment by XRRH2008 on Jun 23, 2017 12:41pm
We most likely do take a big hit here. We already have. Months of taking hits. And a share consolidation not tied to a major event is NOT smart management. It signals a lack of strategy and a lack of capital markets knowledge. You do these types of things when you got nothing left up the sleeve to create shareholder value. She's not making room for institutional investors by doing a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities